Translational Research In Oncology

Clinical research is centered on intermediate-stage hepatocellular carcinoma, with attention to disease burden that extends beyond the up-to-7 criteria. The funded trial activity focuses on treatment strategies for liver cancer in patients who are not suited to straightforward local management alone.

• Intermediate-stage HCC
• Beyond up-to-7 criteria
• Liver malignancy

The trial landscape reflects interest in refining care for patients with hepatocellular carcinoma where tumor extent and clinical complexity require specialized oncologic decision-making.